Three-Component Coupling of Aldehydes, Aminopyrazoles, and Sulfoxonium Ylides via Rhodium(III)-Catalyzed Imidoyl C-H Activation: Synthesis of Pyrazolo[1,5- a]pyrimidines
- PMID: 30525637
- PMCID: PMC6467769
- DOI: 10.1021/acs.joc.8b02606
Three-Component Coupling of Aldehydes, Aminopyrazoles, and Sulfoxonium Ylides via Rhodium(III)-Catalyzed Imidoyl C-H Activation: Synthesis of Pyrazolo[1,5- a]pyrimidines
Abstract
An efficient, three-component strategy for Rh(III)-catalyzed annulation of readily available 3-aminopyrazoles, aldehydes, and sulfoxonium ylides to give diverse pyrazolo[1,5- a]pyrimidines is disclosed. The reactions were performed under straightforward benchtop conditions using microwave heating with short reaction times. Good yields were obtained for many substituted aminopyrazoles and a very large variety of aromatic and heteroaromatic aldehydes, including those incorporating electron-withdrawing, electron-donating, basic nitrogen, halide and acidic functionality. Ester and methoxy functionalities could also be directly installed on the pyrimidine ring by employing ethyl glyoxylate and trimethyl orthoformate in place of the aldehyde, respectively. In addition, a range of sulfoxonium ylides provided products in good yields to establish that aryl, heteroaryl, and branched and unbranched alkyl substituents can be introduced with this reagent. Finally, the first use of a formyl sulfoxonium ylide in a chemical transformation enabled the preparation of products with only a single substituent on the pyrimidine ring as introduced by the aldehyde coupling partner. For the formyl ylide, a one-pot, stepwise reaction sequence was used to prevent competitive condensation of the formyl group with the aminopyrazole.
Conflict of interest statement
Notes
The authors declare no competing financial interest
Figures









References
-
-
For representative approved drugs and clinical candidates of the pyrazolopyrimidine subclass, see: zaleplon, anagliptin, larotrectinib sulfate, indiplon, remeglurant, verucerfont, lorediplon, ropotrectinib, decoglurant, presatovir, ocinaplon, dinaciclib, TAK-43, IPI-549, OT-7100, AVN-322, AVN-211, MK-8776. The compound structure, bioactivity, list of literature, and access to ongoing clinical trials, applications, and usage can be obtained by searching the compound name in PubChem.
-
-
-
For representative approved drugs and clinical candidates within this heterocycle framework outside of the pyrazolopyrimidine subclass, see: zolpidem, alpidem, olprinone, zolimidine, miroprofen, necopidem, saripidem, minodronic acid, GSK812397, soraprazan, divaplon, fasiplon. The compound structure, bioactivity, list of literature, and access to ongoing clinical trials, applications, and usage can be obtained by searching the compound name in PubChem.
-
-
-
For reviews on the synthesis of nitrogen heterocycles by C–H functionalization, see; For select reviews, see:
Satoh T; Miura M Oxidative Coupling of Aromatic Substrates with Alkynes and Alkenes under Rhodium Catalysis. Chem. Eur. J 2010, 16, 11212–11222.
Yamaguchi J; Yamaguchi AD; Itami K C–H Bond Functionalization: Emerging Synthetic Tools for Natural Products and Pharmaceuticals. Angew. Chem. Int. Ed 2012, 51, 8960–9009.
Song G; Wang F; Li X C–C, C–O and C–N Bond Formation via Rhodium(III)-Catalyzed Oxidative C-H Activation. Chem. Soc. Rev 2012, 41, 3651–3678.
Gulías M; Mascareñas JL Metal-Catalyzed Annulations through Activation and Cleavage of C–H Bonds. Angew. Chem. Int. Ed 2016, 55, 11000–11019.
Yoshino T; Matsunaga S (Pentamethylcyclopentadienyl)cobalt(III)-Catalyzed C–H Bond Functionalization: From Discovery to Unique Reactivity and Selectivity. Adv. Synth. Catal 2017, 359, 1245–1262.
Hummel JR; Boerth JA; Ellman JA Transition-Metal-Catalyzed C–H Bond Addition to Carbonyls, Imines, and Related Polarized π Bonds. Chem. Rev 2017, 117, 9163–9227.
-
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources